|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 July 2001, Vol. 98, No. 2, pp. 422-427
NEOPLASIA
Identification of myelodysplastic syndrome-specific
genes by DNA microarray analysis with purified hematopoietic stem
cell fraction
Akira Miyazato,
Shuichi Ueno,
Ken Ohmine,
Masuzu Ueda,
Koji Yoshida,
Yoshihiro Yamashita,
Takashi Kaneko,
Masaki Mori,
Keita Kirito,
Masaki Toshima,
Yuichi Nakamura,
Kenji Saito,
Yasuhiko Kano,
Shinpei Furusawa,
Keiya Ozawa, and
Hiroyuki Mano
From the Divisions of Functional Genomics, Hematology,
Cardiology, and Molecular Immunology, Jichi Medical School,
Kawachi-gun, Tochigi, Japan; Department of Hematology, Dokkyo
University School of Medicine, Mibu, Tochigi, Japan; and Tochigi Cancer
Center, Utsunomiya, Tochigi, Japan.
Myelodysplastic syndrome (MDS) is a slowly progressing hematologic
malignancy associated with a poor outcome. Despite the relatively high
incidence of MDS in the elderly, differentiation of MDS from de novo
acute myeloid leukemia (AML) still remains problematic. Identification
of genes expressed in an MDS-specific manner would allow the molecular
diagnosis of MDS. Toward this goal, AC133 surface marker-positive
hematopoietic stem cell (HSC)-like fractions have been collected from a
variety of leukemias in a large-scale and long-term genomics project,
referred to as "Blast Bank," and transcriptome of these purified
blasts from the patients with MDS were then compared with those from
AML through the use of oligonucleotide microarrays. A number of genes
were shown to be expressed in a disease-specific manner either to MDS
or AML. Among the former found was the gene encoding the protein
Delta-like (Dlk) that is distantly related to the Delta-Notch family of
signaling proteins. Because overexpression of Dlk may play a role in
the pathogenesis of MDS, the disease specificity of Dlk expression was
tested by a quantitative "real-time" polymerase chain reaction analysis. Examination of the Blast Bank samples from 22 patients with MDS, 31 with AML, and 8 with chronic myeloid leukemia
confirmed the highly selective expression of the Dlk gene
in the individuals with MDS. Dlk could be the first candidate molecule
to differentiate MDS from AML. The proposal is made that microarray
analysis with the Blast Bank samples is an efficient approach to
extract transcriptome data of clinical relevance for a wide range of
hematologic disorders.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L. Nilsson, P. Eden, E. Olsson, R. Mansson, I. Astrand-Grundstrom, B. Strombeck, K. Theilgaard-Monch, K. Anderson, R. Hast, E. Hellstrom-Lindberg, et al.
The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes
Blood,
October 15, 2007;
110(8):
3005 - 3014.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. P. Steensma
The spectrum of molecular aberrations in myelodysplastic syndromes: in the shadow of acute myeloid leukemia
Haematologica,
June 1, 2007;
92(6):
723 - 727.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ganser, M. A. Morgan, and E. M. Weissinger
Going from genes to proteins in myelodysplastic syndromes
PNAS,
January 23, 2007;
104(4):
1109 - 1110.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Guglielmelli, R. Zini, C. Bogani, S. Salati, A. Pancrazzi, E. Bianchi, F. Mannelli, S. Ferrari, M.-C. Le Bousse-Kerdiles, A. Bosi, et al.
Molecular Profiling of CD34+ Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (WT1)
Stem Cells,
January 1, 2007;
25(1):
165 - 173.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Pellagatti, M. Cazzola, A. A. N. Giagounidis, L. Malcovati, M. G. D. Porta, S. Killick, L. J. Campbell, L. Wang, C. F. Langford, C. Fidler, et al.
Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype
Blood,
July 1, 2006;
108(1):
337 - 345.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. C. Briggs, K. E. Shults, L. A. Flye, S. A. McClintock-Treep, M. H. Jagasia, S. A. Goodman, F. I. Boulos, J. W. Jacobberger, G. T. Stelzer, and D. R. Head
Dysregulated Human Myeloid Nuclear Differentiation Antigen Expression in Myelodysplastic Syndromes: Evidence for a Role in Apoptosis.
Cancer Res.,
May 1, 2006;
66(9):
4645 - 4651.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Tefferi
Pathogenesis of Myelofibrosis With Myeloid Metaplasia
J. Clin. Oncol.,
November 20, 2005;
23(33):
8520 - 8530.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Sternberg, S. Killick, T. Littlewood, C. Hatton, A. Peniket, T. Seidl, S. Soneji, J. Leach, D. Bowen, C. Chapman, et al.
Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome
Blood,
November 1, 2005;
106(9):
2982 - 2991.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Komor, S. Guller, C. D. Baldus, S. de Vos, D. Hoelzer, O. G. Ottmann, and W.-K. Hofmann
Transcriptional Profiling of Human Hematopoiesis During In Vitro Lineage-Specific Differentiation
Stem Cells,
September 1, 2005;
23(8):
1154 - 1169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Tehranchi, R. Invernizzi, A. Grandien, B. Zhivotovsky, B. Fadeel, A.-M. Forsblom, E. Travaglino, J. Samuelsson, R. Hast, L. Nilsson, et al.
Aberrant mitochondrial iron distribution and maturation arrest characterize early erythroid precursors in low-risk myelodysplastic syndromes
Blood,
July 1, 2005;
106(1):
247 - 253.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Passioura, A. Dolnikov, S. Shen, and G. Symonds
N-Ras-Induced Growth Suppression of Myeloid Cells Is Mediated by IRF-1
Cancer Res.,
February 1, 2005;
65(3):
797 - 804.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Chen, W. Zeng, A. Miyazato, E. Billings, J. P. Maciejewski, S. Kajigaya, E. M. Sloand, and N. S. Young
Distinctive gene expression profiles of CD34 cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities
Blood,
December 15, 2004;
104(13):
4210 - 4218.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. L. Ebert and T. R. Golub
Genomic approaches to hematologic malignancies
Blood,
August 15, 2004;
104(4):
923 - 932.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Liesveld, C. T. Jordan, and G. L. Phillips II
The Hematopoietic Stem Cell in Myelodysplasia
Stem Cells,
July 1, 2004;
22(4):
590 - 599.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Chiaretti, X. Li, R. Gentleman, A. Vitale, M. Vignetti, F. Mandelli, J. Ritz, and R. Foa
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival
Blood,
April 1, 2004;
103(7):
2771 - 2778.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-K. Hofmann, S. de Vos, M. Komor, D. Hoelzer, W. Wachsman, and H. P. Koeffler
Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow
Blood,
November 15, 2002;
100(10):
3553 - 3560.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Qian, A. A. Fernald, L. A. Godley, R. A. Larson, and M. M. Le Beau
Expression profiling of CD34+ hematopoietic stem/ progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia
PNAS,
November 12, 2002;
99(23):
14925 - 14930.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Schoch, A. Kohlmann, S. Schnittger, B. Brors, M. Dugas, S. Mergenthaler, W. Kern, W. Hiddemann, R. Eils, and T. Haferlach
Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles
PNAS,
July 23, 2002;
99(15):
10008 - 10013.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. J. Giles, A. Keating, A. H. Goldstone, I. Avivi, C. L. Willman, and H. M. Kantarjian
Acute Myeloid Leukemia
Hematology,
January 1, 2002;
2002(1):
73 - 110.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
P. L. Greenberg, N. S. Young, and N. Gattermann
Myelodysplastic Syndromes
Hematology,
January 1, 2002;
2002(1):
136 - 161.
[Abstract]
[Full Text]
|
|
|
| |
